FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021

Download FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021

You can download the FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021 for free using the direct download link given at the bottom of this article.

File nameFAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021
No. of Pages18
File size825 KB
Date AddedJul 29, 2022
CategoryGeneral
LanguageEnglish
Source/CreditsDrive Files

FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Overview

  • GENERAL
  • VACCINE ATTRIBUTES
  • EFFICACY & PROTECTION
  • SIDE-EFFECTS
  • PRECAUTIONS
  • FOLLOW-UP & BOOSTER
  • COVID-19 VACCINATION PROGRAM
  • COVID-19 VACCINATION IN PREGNANT AND LACTATING WOMEN

B. VACCINE ATTRIBUTES

  1. What technology has been used in development of the currently available vaccines in India?
    Covishield vaccine, manufactured by the Serum Institute of India, is a Viral Vector-based
    Technology which is also used to manufacture Ebola vaccine.
    Covaxin vaccine, manufactured by the Bharat Biotech, is a whole-Virion Inactivated Corona
    Virus Vaccine which is also used to manufacture vaccines like Influenza, Rabies and Hepatitis-A.
    Sputnik V is developed by Gamaleya Institute in Russia and is working closely with Dr
    Reddy’s Laboratories for Gam-COVID-Vac Combined vector vaccine.
  2. What are the compositions of the above vaccines?
    Composition of Covishield includes inactivated adenovirus with segments of Corona Virus, Aluminium Hydroxide Gel, L-Histidine, L-Histidine hydrochloride monohydrate, Magnesium chloride hexahydrate, Polysorbate 80, Ethanol, Sucrose, Sodium chloride, and Disodium edetate dihydrate (EDTA).
    Composition of Covaxin includes inactivated Corona Virus, Aluminium Hydroxide Gel, TLR 7/8 agonist, 2-Phenoxyethanol and Phosphate Buffered Saline
    Composition of Sputnik V: Component I Active substance: replication incompetent recombinant adenovirus serotype 26 particles containing the SARS-CoV-2 protein S gene. Component II Active substance: replication incompetent recombinant adenovirus serotype 5 particles containing SARS-CoV-2 protein S gene.
    Excipients: Tris (hydroxymethyl) aminomethane, sodium chloride, sucrose, magnesium chloride hexahydrate, EDTA disodium salt dihydrate, polysorbate-80, ethanol 95%, and water for injection.
  3. All three vaccines require cold chain temperature. How is the cold chain been
    maintained during storage and transportation of vaccine?

    The two vaccines (Covishield & Covaxin) need to be stored and transported at +20 to +8⁰ Celsius. The cold chain for the vaccines is maintained through active and passive cold chain equipment available at approximately 29,000 cold chain points across India. Sputnik V requires storage temperature of -180C (minus eighteen degrees centigrade) or below. The deep freezers are available under Universal Immunization Programme across the country for storage of this vaccine.
  4. Is COVISHIELD same as the vaccine been given in UK by Astra Zeneca?
    Yes, Covishield® vaccine, manufactured by the Serum Institute of India, is based on the same patent technology as the AstraZeneca vaccine.
  5. What is the dose schedule of the vaccines under the national vaccination program?
    As per the permission granted by the Drugs Controller General (India), the dose schedule is
    as follows:
    Covishield: two doses, an interval of 12-16 weeks
    Covaxin: two doses at an interval of 4-6 weeks
FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021

FAQs on COVID-19 Vaccines and Vaccination Program-MoHFW Release on 01-09-2021 Download Link

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.